Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_4
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (16.7%)
N/A5 (83.3%)

Trials by Status

completed571%
unknown114%
terminated114%

Recent Activity

0 active trials
Showing 5 of 7
completednot_applicable

Control Trial of Intermittent Hemodialysis With Regional Citrate VS Priming Heparin With Predilution in Patients at Risk of Bleeding

NCT03562754
terminatedphase_4

Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.

NCT06646328
completednot_applicable

No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation

NCT04792424
completednot_applicable

Citrate Versus Heparin in Continuous Renal Replacement Therapy :

NCT04865510
unknownnot_applicable

RCA for CRRT in Liver Failure and High Risk Bleeding Patients

NCT03791190
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03562754Not Applicable

Control Trial of Intermittent Hemodialysis With Regional Citrate VS Priming Heparin With Predilution in Patients at Risk of Bleeding

Completed
NCT06646328Phase 4

Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.

Terminated
NCT04792424Not Applicable

No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation

Completed
NCT04865510Not Applicable

Citrate Versus Heparin in Continuous Renal Replacement Therapy :

Completed
NCT03791190Not Applicable

RCA for CRRT in Liver Failure and High Risk Bleeding Patients

Unknown
NCT02281045Not Applicable

CITrate and Evodial for Effective Dialysis (CITED) Study

Completed
NCT00583765

Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration

Completed

All 7 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
7